CONTACT INFORMATION:Bioponic Phytoceuticals, Inc.
P.O. Box 2120
Kihei, HI 96753
Steven M. Schorr (CEO, Bioponic Phytoceuticals):
Fax: Fax: 808-876-1784
Geoffrey Eiten (Investor Relations, OTC Financial Network)
Telephone: 1-781-444-6100 x613
LINK TO FINANCIAL STATEMENTS:
TRADING EXCHANGE LISTING: Pink Sheets
Bioponic Phytoceuticals is engaged in the development, production and distribution of Bioresonant PhytotherapeuticTM products for sale in the Complementary Alternative Medicine markets, as well as nutraceutical products for the flavor and fragrance industries. The Company has several branded product lines in distribution and is focused on products that are used to promote health and well-being.
PRIMARY SIC INDUSTRY CLASSIFICATION:
2833 - Medicinal and botanicals
STATE OF INCORPORATION: Delaware
YEAR OF INCORPORATION: 2000
Steven M. Schorr, Chairman, CEO
Gary Abreim, CFO
Hamiel O. Schorr, VP
NUMBER OF EMPLOYEES: 12 (as of Dec 31, 2006)
SEC REPORTING STATUS: Non-SEC Reporting Company
FISCAL YEAR END: 09/30
Authorized Shares: 200,000,000 (as of Jun 30, 2007)
Shares Outstanding: Feb. 6, 2008: 42,798,290 (as of Feb 06, 2008)
Float: 5,000,000 (as of Jun 30, 2007)
Share Holders of Record: 593 (as of Jun 30, 2007)
Computershare Trust Company Inc.
350 Indiana St.
Golden, CO 80401
Pohl, McNabola, Berg & Company, LLP
50 San Francisco St.
San Francisco, CA 94133-2108
Frank J. Hariton
1065 Dobbs Ferry Road
White Plains, NY 10607
INVESTOR RELATIONS FIRM:
OTC Financial Network
300 Chestnut Street
Needham, MA 02492
DISCLAIMER: Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have positions in the stocks or financial relationships with the company or companies discussed and may trade in the stocks mentioned. Readers are advised to conduct their own due diligence prior to considering buying or selling any stock. All information should be considered for information purposes only. No stock exchange has approved or disapproved of the information contained herein.